CJC-1295 w/o DAC

CJC-1295, when administered without a DAC, mimics the action of GHRH. This binding to GHRH receptors in the pituitary gland triggers an increase in the secretion of growth hormone. Consequently, it can lead to various physiological benefits, such as muscle growth, fat loss, and improved recovery times.

All products are intended for in vitro or laboratory research use only. This compound is not intended for therapeutic or diagnostic purposes and has not been approved by the FDA for human or veterinary use.

** This product is in lyophilized powder form and requires reconstitution solution (BAC Water) for research.